Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer.

The Journal of surgical research - 1 Dec 2007

Bartoletti Riccardo, Cai Tommaso, Nesi Gabriella, Roberta Girardi Lucia, Baroni Gianna, Dal Canto Maurizio

Abstract excerpt

OBJECTIVES: To evaluate the prognostic role of p16 expression and loss of heterozygosity (LOH) on chromosome 9p21 in patients affected by low-grade (G1-G2) urothelial bladder cancer. METHODS: Fifty-six consecutive patients with diagnosis of urothelial bladder cancer were enrolled in this prospective study. LOH analysis was performed on a blood/tumor pair sample of each patient, by using polymerase chain reaction...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosomes, Human, Pair 9
Share to Cyclin-Dependent Kinase Inhibitor p16

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Kaplan-Meier Estimate

Share to Loss of Heterozygosity

Share to Multivariate Analysis

Share to Neoplasm Recurrence, Local

Share to Urinary Bladder Neoplasms

Share to Urothelium

Source

Identifiers

PMID: 17612565
DOI: 10.1016/j.jss.2007.01.012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer.PMID 17612565Read ↗

Loss of chromosome 9p21 and decreased p16 expression correlate with malignant gastrointestinal stromal tumor.Semantic proximity Read ↗

Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder.Semantic proximity Read ↗

Decreased expression of the p16/MTS1 gene without mutation is frequent in human urinary bladder carcinomas.Semantic proximity Read ↗

p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer.Semantic proximity Read ↗

Microsatellite alterations at chromosomes 9p, 13q, and 17p in nonmuscle-invasive transitional cell carcinomas of the urinary bladder.Semantic proximity Read ↗

Loss of heterozygosity of D9S162: molecular predictor for treatment response in oral carcinoma.Semantic proximity Read ↗

Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder.Semantic proximity Read ↗

Analysis of genetic alterations in normal bladder urothelium.Semantic proximity Read ↗

Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction.Semantic proximity Read ↗

Genetic alterations in bladder cancer.Semantic proximity Read ↗

Deletion of the p16 and p15 Genes in Human Bladder TumorsSemantic proximity Read ↗

Loss of heterozygosity on chromosome 9q and p53 alterations in human bladder cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.